Top compounds associated with response to SMLR1


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.07 0.04
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.07 0.05
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.07 0.05
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC -0.16 0.05
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC -0.18 0.05
mRNA phloretin CTRPv2 pan-cancer AAC 0.067 0.05
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.05
mRNA niclosamide CTRPv2 pan-cancer AAC -0.07 0.05
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.092 0.05
Download CSV